21.79
Dianthus Therapeutics Inc Aktie (DNTH) Neueste Nachrichten
Is Dianthus Therapeutics Inc. a good long term investmentExplosive portfolio gains - jammulinksnews.com
What drives Dianthus Therapeutics Inc. stock priceHigh-profit trading signals - jammulinksnews.com
Dianthus Therapeutics Inc. Stock Analysis and ForecastSuperior portfolio returns - jammulinksnews.com
What analysts say about Dianthus Therapeutics Inc. stockGame-changing returns - jammulinksnews.com
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 5.9%Should You Buy? - MarketBeat
Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $53.00 - MarketBeat
why dianthus therapeutics inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
what makes dianthus therapeutics inc. stock price move sharplyVolume Spike Monitors - Newser
What makes Dianthus Therapeutics Inc. stock price move sharplyFree Deep Market Trend Analysis - Newser
How Dianthus Therapeutics Inc. stock performs during market volatilityFree Stock Selection - Newser
Why Dianthus Therapeutics Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.9%Should You Sell? - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 8.4%Should You Buy? - MarketBeat
DNTH’s Stock Market Adventure: -16.38% YTD Growth Amidst Volatility - investchronicle.com
What is William Blair's Estimate for DNTH FY2025 Earnings? - MarketBeat
William Blair Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
FY2025 Earnings Estimate for DNTH Issued By William Blair - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated at William Blair - Defense World
Dianthus Therapeutics stock rises after William Blair initiates coverage By Investing.com - Investing.com Canada
Dianthus Therapeutics Shares Climb After Analyst Coverage Boost - MSN
William Blair Initiates Dianthus Therapeutics at Outperform - MarketScreener
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):